See the DrugPatentWatch profile for Phytonadione
What is phytonadione injection used for?
Phytonadione injection is a form of vitamin K used to treat or prevent conditions caused by vitamin K deficiency, where blood does not clot normally. It is used for bleeding due to vitamin K deficiency and in situations where oral vitamin K can’t be used.
It’s commonly associated with management of excessive bleeding risk from impaired vitamin K–dependent clotting factors, including bleeding in newborns related to vitamin K deficiency.
How does phytonadione injection work?
Vitamin K is needed to activate clotting factors in the liver (vitamin K–dependent factors). When vitamin K is low, those clotting factors don’t work properly, which increases bleeding risk. Phytonadione replenishes vitamin K so clotting can return toward normal.
How is phytonadione injection given (route and timing)?
Phytonadione injection can be given by healthcare professionals, with routes depending on the clinical situation and local prescribing practices (for example, intravenous or intramuscular use in some settings). Timing is typically based on the urgency of bleeding and the underlying cause.
Who might need phytonadione injection?
People may be candidates when vitamin K deficiency is suspected or known, such as:
- Bleeding caused by vitamin K deficiency
- Newborns at risk of vitamin K deficiency bleeding
- Patients who cannot take vitamin K by mouth, or who need rapid correction in a clinical setting
What are the risks and side effects patients ask about?
Common expectations for vitamin K injections are generally limited, but side effects can include reactions at the injection site and hypersensitivity reactions in some patients. The risk profile also depends on the route of administration and the person’s clinical status. Clinicians typically screen for allergy history and monitor response.
Are there important drug interactions?
Phytonadione is most often discussed in the context of anticoagulation therapy. Vitamin K status can affect how well vitamin K–dependent clotting factors work, which is why clinicians pay close attention when patients are taking medicines that interfere with vitamin K pathways.
When do doctors consider dosing changes or alternatives?
Dosing can change based on:
- The reason for treatment (prophylaxis vs active bleeding)
- Age (especially newborn dosing considerations)
- The cause of deficiency (dietary lack, malabsorption, medication-related effects)
- Severity of coagulopathy and the urgency to correct bleeding
If you tell me the context (newborn prophylaxis, treatment of bleeding, or a specific cause such as anticoagulant use), I can narrow down the most relevant practical details.